• DEVENEZ MEMBRE
    Pour un accès complet à theheart.org
    À titre de membre permanent, vous pourrez accéder au contenu éditorial et de formation continue, utiliser le moteur de recherche, recevoir nos newsletters, participer aux discussions, télécharger des diapositives et plus encore.

    L'abonnement est gratuit !
    Inscrivez-vous maintenant !
    Obtenez un accès limité de 30 jours aux articles de heartwire
    Professionnel de la santé   Oui Non
    Obtenez un accès limité !

CCC 2011 - Vancouver, BC

Heartwire

Brain/Kidney/Peripheral
Fludrocortisone flops for vasovagal syncope: POST 2
1 COMMENT - Oct 28, 2011 15:15 EDT
A trial seven years in the making has found no statistically significant benefit for the mineralocorticoid fludrocortisone in a young, mostly female population with moderate to severe vasovagal syncope.
Clinical cardiology
Esomeprazole, but not rosuvastatin, affects clopidogrel post-PCI: SPICE
5 COMMENTS - Oct 27, 2011 15:45 EDT
Esomeprazole is "at least as bad" as omeprazole in reducing the antiplatelet effects of clopidogrel, a new randomized trial shows, but when it comes to statin effects, SPICE found no differences between rosuvastatin and atorvastatin on platelet function.
Clinical cardiology
Bupropion no "magic bullet" in post-MI smokers
11 COMMENTS - Oct 27, 2011 10:45 EDT
A rare trial looking at a smoking-cessation drug given to older, long-time smokers immediately post-AMI has found no benefits of bupropion at one year, suggesting that despite a "life-changing event," smokers struggle to kick the habit.
Fat, unfit, unmotivated: Cardiologist, heal thyself
Prevention
Fat, unfit, unmotivated: Cardiologist, heal thyself
31 COMMENTS - Oct 26, 2011 09:30 EDT
If they truly want to help patients eat better, lose weight, and exercise more, cardiologists need to take a good hard look at themselves and put that discomfort to good use, says Dr Brian McCrindle.
Arrhythmia/EP
EaSyAs II boosts role for implantable loop recorder
1 COMMENT - Oct 26, 2011 08:20 EDT
Investigators say implantation of an ILR significantly shortened times to ECG-directed diagnosis and therapy, even when patients were not encouraged to also check in with a syncope clinic.
What's
Imaging
What's "normal?" Little consensus on CAD extent, severity among Ontario angiographers
6 COMMENTS - Oct 25, 2011 11:45 EDT
A fundamental first step to understanding appropriateness of revascularization procedures is reaching some agreement as to what represents significant disease, researchers say.
STEMI transfer and treatment: What works, what doesn't
Interventional/Surgery
STEMI transfer and treatment: What works, what doesn't
1 COMMENT - Oct 25, 2011 09:00 EDT
A pitched effort by the Quebec Ministry of Health to understand how STEMI care is managed in that province should spur some much-needed discussion as to what works and what doesn't in the management of these patients.
Many low/intermediate-risk patients still get aspirin for primary prevention: PARADIGM
Prevention
Many low/intermediate-risk patients still get aspirin for primary prevention: PARADIGM
14 COMMENTS - Oct 24, 2011 10:45 EDT
When investigators for the PARADIGM registry reviewed the use of cardiovascular medications prescribed by family physicians to more than 3000 healthy, middle-aged Canadians, they found that almost 14% were prescribed aspirin. The million-dollar question was, why?
Prevention
Stones and glass houses: Canada's cardiovascular profile parallels US
Oct 24, 2011 08:45 EDT
Canadians who tend to pride themselves on being healthier, generally, than their neighbors south of the border need to take a cold hard look at CVD trends in their own country, according to American cardiologist Dr Clyde Yancy.

Discussion and opinions